Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management
Welcome Guest
Sign In
Register
News
Events
Articles
Product Center
Featured Products
Videos
Register
Sign In
AdGlare Leaderboard
OphthalmologyWeb
Product Center
Neuro-Ophthalmology
Visual Field Test / Visual Field Testing Supplies and Equipment
Goldmann Visual Field Kinetic Perimetry Test
Goldmann Visual Field Kinetic Perimetry Test
Showing 1 of 1 products
<<
<
>
>>
Sort By
- select -
Item Name
Company Name
Price
Get quotes for all products
Select All
Select up to 5 products from below to compare or request more information.
Compare
Compare
or
Get quote
for selected.
Octopus 900 Perimeter
Haag-Streit USA, Inc.
Stimulus:
Mirror projection system
Fixation Control:
Blink Control, Pupil Position Control, AET (Automated Eye Tracking)
Test Strategies:
TOP (Tendency Oriented Perimetry, 2–4 min)
Dynamic (adaptive step size, 6–8 min)
Normal (4-2-1 bracketing, 10–12 min)
Other (LV: Low Vision with Goldmann size V; 2-LT: 2-Level Test, 1-LT: 1-Level Test; GST: Glaucoma Screening Test)
Analysis Software:
EyeSuite™ Software Analysis with networkable system and EMR Integration.
Read More
Get quote
Select All
Select up to 5 products from above to compare or request more information.
Compare
Tags:
Please Login or Register to Create Tags
Feedback
Articles
Difficulty Reading: An Unusual Case Report
Octopus 900 Perimeter
Help
Use this product listing in multiple ways:
Click
Get Quote
to receive a quote from the vendor for that product
Check up to 5 products and click to
compare
to view product specifications side by side or
Get quote
to get a quote for all your selected products
Click
Get quotes for all products
at the top of the list to get a quote for all products
advertisement
Related Articles
Over 4 Million U.S. Adults Have Glaucoma According...
Friday, November 01, 2024
Epioxa™ Shows Efficacy in Treating Keratoconus in ...
Friday, October 25, 2024
6-Year Data Demonstrates Effective IOP Reduction ...
Wednesday, November 15, 2023
ICare HOME2 Tonometer for Glaucoma Receives FDA ...
Wednesday, March 30, 2022
First Patient Treated in TRIDENT Trial Evaluating ...
Monday, March 28, 2022
AdGlare RMR2